ABG-WTT Global Life Science Capital Partners GP Ltd Long-Term Concentrated

Name: ABG-WTT Global Life Science Capital Partners GP Ltd Q1 2022 13F Filing | 13F Explorer
Creator: ABG-WTT Global Life Science Capital Partners GP Ltd
Published: 2022-05-16

Location: Central, Hong Kong, Hong Kong

CIK: 0001832108 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $12.32M (100.0% shares, 0.0% debt)

Holdings (3)

RPID Rapid Micro Biosystems Inc 57.2%

Value $7.05M Shares 1,038,296 Est. Cost $7.36 Unrealized 0.0%

— MEDAVAIL HOLDINGS INC 30.6%

Value $3.774M Shares 3,885,951 Est. Cost $15.05 Unrealized —

LUNG PULMONX CORP 12.1%

Value $1.494M Shares 60,204 Est. Cost $48.97 Unrealized -47.3%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
RPID	Rapid Micro Biosystems Inc	1,038,296	$7.05M	57.2%	$7.36	0.0%	CLASS A COM	75340L104
—	MEDAVAIL HOLDINGS INC	3,885,951	$3.774M	30.6%	$15.05	—	COM	58406B103
LUNG	PULMONX CORP	60,204	$1.494M	12.1%	$48.97	-47.3%	COM	745848101